Washington Examiner on MSN17d
FDA approves new painkiller that shows promise and challenges of opioid alternativesVertex has attracted interest from Wall Street for its ambitious drug pipeline that involves winning FDA approval for multiple drugs across several forms of chronic pain, which generally represents a ...
NBC News on MSN16d
FDA approves new type of nonopioid painkiller for acute paincreating feelings of euphoria and activating the brain’s reward system. That’s why opioids can be incredibly addictive. Vertex’s drug works in a completely different way, by blocking the pain signal ...
A non-opioid pain medication made by Vertex Pharmaceuticals has received approval for adults from the Food and Drug Administration (FDA).
A new pain relief drug, suzetrigine, is a prescription pill that’s taken every 12 hours after a larger starter dose. It will ...
Vertex Pharmaceuticals ( VRTX 2.53%) has long been known as the company to turn to for life-saving cystic fibrosis (CF) drugs ...
The drug, Journavx by Vertex Pharmaceuticals, blocks pain signals to the brain, making it nonaddictive. By Gina Kolata The Food and Drug Administration approved a new medication Thursday to treat ...
Vertex's drug works differently, blocking proteins that trigger pain signals that are later sent to the brain. "In trying to develop medicines that don't have the addictive risks of opioid ...
blocking pain signals from reaching the brain to begin with. As a result, Vertex executives say, it cannot cause addiction and is worth considerably more than an opioid, especially considering the ...
(Vertex Pharmaceuticals via AP) Opioids reduce pain by binding to receptors in the brain that receive nerve signals from different parts of the body. Those chemical interactions also give rise to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results